Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryoablation + Sintilimab + Lenvatinib in Advanced Intrahepatic Cholangiocarcinoma
NCT05010668Phase 2Completed
- Sponsor
- Fudan University
- Start
- Aug 2021
- Primary completion
- Mar 2024
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab, lenvatinib in intrahepatic cholangiocarcinoma (ICC), sponsored by Fudan University. Started Aug 2021; status: completed.
02
Drugs
sintilimablenvatinib
03
Conditions
intrahepatic cholangiocarcinoma (ICC)
Beyond the preview
Go deeper on NCT05010668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05010668.